Product Information

NEBIVOLOL 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1119 per EA under NDC 00904749804. Its NADAC has been published 61 times since Jun 25, 2025.

FDA first approved this application on Apr 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the nebivolol market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for NEBIVOLOL 5 MG TABLET has been published 61 times since Jun 25, 2025, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.